A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Conditions
Rheumatoid Arthritis (RA)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nouvelle Clinical Research LLC, Cutler Bay, Florida, United States
Millennium Medical Research LLC, Miami, Florida, United States
Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States
Diagnostic Consultative Center Aleksandrovska, Sofia, Bulgaria
Medical Center Tera Medico, Vratsa, Bulgaria
Sanos Clinic Herlev, Herlev, Denmark
IMSP Spitalul Clinic Municipal "Sfanta Treime", Chisinau, Moldova
M2Mmed, Chorzów, Poland
Vita Longa Sp. z o. o., Katowice, Poland
Medyczne Centrum Hetmańska, Poznan, Poland
DC-MED Michal Kowalski S.K., Swidnica, Poland